POST-APPROVAL SAFETY STUDY (PASS) OF THE UTILIZATION PATTERN OF APIXABAN IN SWEDEN

19/11/2013
13/03/2024
EU PAS number:
EUPAS5177
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

cv185103st-prot (pfizer-protocol-b0661017)

English (127.33 KB - PDF) View document
Updated protocol

cv185103st-prot-may2015 (pfizer-protocol-b0661017)-red

First published: 22/02/2024
English (1.53 MB - PDF) View document
Study results
Study results

study-cv185103st-csr-final-red

English (1.09 MB - PDF) View document
Study report
Other information